An adult patient with permanent neonatal diabetes successfully discontinued insulin therapy after initiating sitagliptin added to sulphonylurea
- 19 January 2021
- journal article
- letter
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 23 (5), 1213-1214
- https://doi.org/10.1111/dom.14318
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort studyThe Lancet Diabetes & Endocrinology, 2018
- Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetesDiabetologia, 2016
- Long-Term Efficacy of Glibenclamide and Sitagliptin Therapy in Adult Patients With KCNJ11 Permanent DiabetesDiabetes Care, 2014
- Switching from Insulin to Oral Sulfonylureas in Patients with Diabetes Due to Kir6.2 MutationsThe New England Journal of Medicine, 2006